Jove
Visualize
Contact Us

Related Experiment Videos

Pheochromocytoma.

C V Ram1

  • 1University of Texas, Southwestern Medical Center, Dallas.

Cardiology Clinics
|November 1, 1988
PubMed
Summary
This summary is machine-generated.

Pheochromocytoma, a rare but curable cause of secondary hypertension, requires high suspicion for diagnosis. Early detection and treatment lead to excellent outcomes, preventing serious complications and death.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Hypertension Optimal Treatment Trial: a precursor for lowering the target blood pressure level.

Current hypertension reports·2000
Same author

Role of angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers in the prevention of progression of renal disease.

Current hypertension reports·2000
Same author

Fibromuscular dysplasia of the renal arteries.

Current hypertension reports·2000
Same author

Fenoldopam, a dopamine agonist, for hypertensive emergency: a multicenter randomized trial. Fenoldopam Study Group.

Academic emergency medicine : official journal of the Society for Academic Emergency Medicine·2000
Same author

Renovascular hypertension.

Current opinion in nephrology and hypertension·1998
Same author

Nonsteroidal anti-inflammatory drugs (NSAIDs) and blood pressure.

The American journal of cardiology·1997
Same journal

At the Edge of the Possible: A New Standard for Cardiovascular Critical Care.

Cardiology clinics·2026
Same journal

End-of-Life Care in the Cardiovascular Intensive Care Unit.

Cardiology clinics·2026
Same journal

Strategies to Reduce Failure to Rescue after Cardiac Surgery.

Cardiology clinics·2026
Same journal

Embracing Enhanced Recovery After Cardiac Surgery Program.

Cardiology clinics·2026
Same journal

Post-Heart Transplantation Intensive Care Unit Recovery: A Phase-Based Approach.

Cardiology clinics·2026
Same journal

A Practical Guide to Intensive Care Unit Management after Left Ventricular Assist Device Implantation.

Cardiology clinics·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Endocrinology
  • Oncology
  • Hypertension Management

Background:

  • Pheochromocytoma is an uncommon cause of secondary hypertension, but it is curable with proper treatment.
  • Untreated pheochromocytoma can lead to severe complications and mortality.
  • Diagnosis relies on clinical suspicion, evaluation, and laboratory testing.

Purpose of the Study:

  • To highlight the importance of early diagnosis and management of pheochromocytoma.
  • To discuss the diagnostic challenges and advancements in identifying pheochromocytoma.
  • To outline the multidisciplinary approach required for effective patient management.

Main Methods:

  • Review of clinical presentations and diagnostic techniques for pheochromocytoma.
  • Emphasis on biochemical and radiologic advancements in diagnosis and localization.

Related Experiment Videos

  • Discussion of surgical and medical management strategies.

    • Main Results:

    • Modern diagnostic techniques have improved pheochromocytoma detection and localization.
    • Despite advancements, some cases remain undiagnosed until complications arise.
    • Surgical removal is the primary treatment, with near-zero mortality when managed medically preoperatively.

    Conclusions:

    • Pheochromocytoma management requires a multidisciplinary approach involving medical, surgical, radiology, and anesthesiology expertise.
    • Understanding pathophysiology is crucial for rational patient management.
    • Chronic medical therapy is an option for inoperable or malignant cases.